Gv medical support, MB - financials and debts

Company age: 2 y. 9 mo.

Update

Gv medical support - Company finances

EUR
2024
From: 2024-01-03
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 4,249 2,460
Profit before tax 141 220
Net profit 141 207
Equity 141 349
Liabilities 0 413
Non-current assets 0 0
Current assets 141 762
Total assets 141 762
Financial indicators
Revenue change y/y - -42.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 100.0% 27.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% 59.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 3.3% 8.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 3.3% 8.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 1.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Gv medical support - Social security debts

The company had no debts to Sodra

Gv medical support - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Gv medical support, MB (code 306652432) is a Small partnership operating in Other education n.e.c. In 2025, the company generated revenue of €2.5K, down 42.1% year on year from €4.2K in 2024. Despite the lower turnover, net profit increased to €207 from €141, and the profit margin improved from 3.3% to 8.4%. The two-year trend shows a business with declining sales but better earnings conversion in the latest year. The balance sheet remains small, with total assets of €762, equity of €349 and liabilities of €413 at the end of 2025. The equity ratio stood at 45.8% and debt-to-equity at 1.18, indicating a moderate leverage position on a limited asset base. Asset turnover was 3.23x, while ROE was 59.3% and ROA 27.2%, reflecting strong returns relative to the very small capital base. No employee data was provided, so revenue per employee cannot be assessed.